Comparison of adults with insulin resistance (IR) in latent autoimmune diabetes versus IR in glutamic acid decarboxylase antibody-negative diabetes

Comparison of adults with insulin resistance (IR) in latent autoimmune diabetes versus IR in glutamic acid decarboxylase antibody-negative diabetes

Introduction: Insulin resistance in latent autoimmune diabetes in adults (LADA) patients is controversial. The aim of this study was to evaluate insulin resistance and its related factors (metabolic syndrome parameters) among subjects with LADA and glutamic acid decarboxylase antibodies (GADA) negat...

Full description

Bibliographic Details
Main Authors:	Salem, S.D., Saif-Ali, R., Muniandy, S., Al-Hamodi, Z., Ismail, I.S.
Format:	Article
Published:	Academy of Medicine, Singapore 2014
Subjects:	R Medicine

Similar Items

IGF2BP2 alternative variants associated with glutamic acid decarboxylase antibodies negative diabetes in Malaysian subjects
by: Salem, S.D., et al.
Published: (2012)

Limbic autoimmune encephalitis with antibodies to glutamate decarboxylase (GAD)
by: L. U. Ulukhanova, et al.
Published: (2020-06-01)

Prevalence of glutamic acid decarboxylase antibodies amongst young Malaysian diabetics
by: Nazaimoon, W.M.W., et al.
Published: (1999)

Estimation of Insulin and Glutamic Acid Decarboxylase Autoantibodies In Patients With Type 1 Diabetes Mellitus
by: Abbas J Mohammed
Published: (2019-06-01)

Estimation of Insulin and Glutamic Acid Decarboxylase Autoantibodies In Patients With Type 1 Diabetes Mellitus
by: Abbas J Mohammed
Published: (2019-06-01)

Antibodies to Glutamic Acid Decarboxylase-65 is Associated with Total Daily Dose of Insulin Requirement in Children with Type 1 Diabetes
by: Faisal Faisal, et al.
Published: (2023-08-01)

Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS
by: Clark, A, et al.
Published: (2005)

Neurological manifestations of glutamic acid decarboxylase autoimmunity in Indian patients
by: Meena Thevarkalam, et al.
Published: (2023-01-01)

A convenient diagnostic tool for discriminating adult-onset glutamic acid decarboxylase antibody-positive autoimmune diabetes from type 2 diabetes: a retrospective study
by: Hon-Ke Sia, et al.
Published: (2020-02-01)

Thrombotic thrombocytopenic purpura with high titers of anti-glutamic acid decarboxylase and anti-insulin antibodies
by: Youichi Yanagawa, et al.
Published: (2023-01-01)

Ataxia associated with anti-glutamic acid decarboxylase antibodies
by: E. P. Nuzhnyi, et al.
Published: (2020-10-01)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
by: Turner, R, et al.
Published: (1997)

Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.
by: Antozzi, C, et al.
Published: (2005)

Study of the prevalence of anti Glutamic Acid Decarboxylase antibody in Iraqi children and adolescent with type 1 Diabetes mellitus
by: Izzat Abdul Satar Mezher, et al.
Published: (2011-12-01)

Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
by: Mendivil CO, et al.
Published: (2017-05-01)

Histidine Decarboxylase Deficiency Prevents Autoimmune Diabetes in NOD Mice
by: Manal Alkan, et al.
Published: (2015-01-01)

Endogenous Levels of Gamma Amino-Butyric Acid Are Correlated to Glutamic-Acid Decarboxylase Antibody Levels in Type 1 Diabetes
by: Henrik Hill, et al.
Published: (2021-12-01)

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
by: Malter, M, et al.
Published: (2010)

AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE AS A PATHOGENETIC MARKER OF TYPE I DIABETES MELLITUS
by: N. V. Piven, et al.
Published: (2014-07-01)

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
by: Turner, R, et al.
Published: (1997)

Anti-Glutamic Acid Decarboxylase Antibody-Associated Ataxia as an Extrahepatic Autoimmune Manifestation of Hepatitis C Infection: A Case Report
by: Amer Awad, et al.
Published: (2011-01-01)

Serum glutamic acid decarboxylase 65 antibody levels in people with schizophrenia and their families.
by: Gaughran, F, et al.
Published: (2005)

Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
by: Honnorat, J, et al.
Published: (2001)

Glutamic Acid Decarboxylase Autoantibodies-Related Encephalitis
by: J Gordon Millichap
Published: (2011-09-01)

Contribution of SLC30A8 variants to the risk of type 2 diabetes in a multi-ethnic population: a case control study
by: Salem, S.D., et al.
Published: (2014)

Immunoprofiling of drug-resistant epilepsy with a focus on glutamic acid decarboxylase 65 antibodies
by: McGinty, R
Published: (2021)

Anti-glutamic acid decarboxylase antibodies-associated cerebellar ataxia: A treatable ataxia
by: Rohan Mahale, et al.
Published: (2024-04-01)

Detection of Glutamate Decarboxylase Antibodies and Simultaneous Multi-Molecular Translocation Exploration by Glass Nanopores
by: Chongxin Tao, et al.
Published: (2024-05-01)

Prediction of future insulin‐deficiency in glutamic acid decarboxylase autoantibody enzyme‐linked immunosorbent assay‐positive patients with slowly‐progressive type 1 diabetes
by: Eiji Kawasaki, et al.
Published: (2024-07-01)

Insulin Resistance Estimated by HOMA IR for Diagnosis of Gestational Diabetes in Squatter Settlement of Karachi
by: Hira Attique, et al.
Published: (2020-01-01)

Glutamic acid decarboxylase auto-antibodies prevalence among patients with type 2 diabetes mellitus and their clinical characteristics in a sample of the Egyptian population
by: Ayat I Ghanem, et al.
Published: (2019-01-01)

Differential diagnostic utilities of combined testing for islet cell antibody, glutamic acid decarboxylase antibody, and tyrosine phosphatase antibody
by: Alexei V. Timofeev, et al.
Published: (2018-05-01)

Glutamic acid decarboxylase antibody-spectrum disorders and type 1 diabetes mellitus in a patient following allogenic hematopoietic cell transplantation with review of literature
by: Shinichiro Sano, et al.
Published: (2025-03-01)

Prevalence of latent autoimmune diabetes in adults and insulin resistance: a systematic review and meta-analysis
by: Malihe Mohammadi
Published: (2024-08-01)

Diabetic Ketoacidosis as First Presentation of Latent Autoimmune Diabetes in Adult
by: Omar Nadhem, et al.
Published: (2015-01-01)

The relationship between insulin hormone and insulin resistance ( IR ) with Lipid profile in people with diabetes(Type I and Type II)
by: Abdullah S. Almawla, et al.
Published: (2018-11-01)

Modern understanding of latent autoimmune diabetes in adults
by: I. I. Golodnikov, et al.
Published: (2023-07-01)

Glucose control in UKPDS type 2 diabetic patients with and without autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase.
by: Mehta, Z, et al.
Published: (1999)

New-onset focal epilepsy with palatal tremor and glutamic acid decarboxylase antibodies responding to intravenous immunoglobulin.
by: Marnane, M, et al.
Published: (2008)

Case report: Approaches to treatment-refractory and super-refractory glutamic acid decarboxylase antibody-spectrum disorders
by: Ravi Rajmohan, et al.
Published: (2024-01-01)